Townsquare Capital LLC Vertex Pharmaceuticals Inc Transaction History

Townsquare Capital LLC

$7.19 Billion
Q2 2024

A detailed history of Townsquare Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Townsquare Capital LLC holds 11,438 shares of VRTX stock, worth $5.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,438

Previous 9,490 20.53%

Holding current value

$5.75 Million

Previous $3.97 Million 35.17%

% of portfolio

0.07%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $765,193 - $945,812	1,948 Added 20.53%	11,438 $5.36 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $291,090 - $318,501	714 Added 8.14%	9,490 $3.97 Million
Q4 2023 Feb 15, 2024	SELL	$343.0 - $410.68 $2.1 Million - $2.52 Million	-6,124 Reduced 41.1%	8,776 $3.57 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $618,531 - $662,939	1,829 Added 13.99%	14,900 $5.18 Million
Q2 2023 Nov 13, 2023	BUY	$314.42 - $351.91 $1.86 Million - $2.09 Million	5,927 Added 82.96%	13,071 $4.6 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $53,247 - $60,742	-188 Reduced 2.56%	7,144 $2.25 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $371,488 - $417,924	1,300 Added 21.55%	7,332 $2.12 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $210,849 - $235,258	770 Added 14.63%	6,032 $1.75 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $371,471 - $462,521	1,581 Added 42.95%	5,262 $1.48 Million
Q1 2022 Apr 28, 2022	BUY	$221.42 - $260.97 $108,717 - $128,136	491 Added 15.39%	3,681 $961,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $218,253 - $275,513	1,233 Added 63.0%	3,190 $701,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $354,980 - $397,251	1,957 New	1,957 $355,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Vertex Pharmaceuticals Inc Transaction History